These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 18669189)
21. The tumour microenvironment, treatment resistance and recurrence in glioblastoma. White J; White MPJ; Wickremesekera A; Peng L; Gray C J Transl Med; 2024 Jun; 22(1):540. PubMed ID: 38844944 [TBL] [Abstract][Full Text] [Related]
22. Patupilone (epothilone B) for recurrent glioblastoma: clinical outcome and translational analysis of a single-institution phase I/II trial. Oehler C; Frei K; Rushing EJ; McSheehy PM; Weber D; Allegrini PR; Weniger D; Lütolf UM; Knuth A; Yonekawa Y; Barath K; Broggini-Tenzer A; Pruschy M; Hofer S Oncology; 2012; 83(1):1-9. PubMed ID: 22688083 [TBL] [Abstract][Full Text] [Related]
23. Multilayered Heterogeneity of Glioblastoma Stem Cells: Biological and Clinical Significance. Brown DV; Stylli SS; Kaye AH; Mantamadiotis T Adv Exp Med Biol; 2019; 1139():1-21. PubMed ID: 31134492 [TBL] [Abstract][Full Text] [Related]
24. Hypoxia differentially upregulates the expression of embryonic, fetal and adult hemoglobin in human glioblastoma cells. Emara M; Turner AR; Allalunis-Turner J Int J Oncol; 2014 Mar; 44(3):950-8. PubMed ID: 24379112 [TBL] [Abstract][Full Text] [Related]
25. Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cells. Chirasani SR; Sternjak A; Wend P; Momma S; Campos B; Herrmann IM; Graf D; Mitsiadis T; Herold-Mende C; Besser D; Synowitz M; Kettenmann H; Glass R Brain; 2010 Jul; 133(Pt 7):1961-72. PubMed ID: 20513660 [TBL] [Abstract][Full Text] [Related]
26. Aberrant self-renewal and quiescence contribute to the aggressiveness of glioblastoma. Campos B; Gal Z; Baader A; Schneider T; Sliwinski C; Gassel K; Bageritz J; Grabe N; von Deimling A; Beckhove P; Mogler C; Goidts V; Unterberg A; Eckstein V; Herold-Mende C J Pathol; 2014 Sep; 234(1):23-33. PubMed ID: 24756862 [TBL] [Abstract][Full Text] [Related]
28. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness. Gao X; Jin W Cancer Lett; 2014 Oct; 353(1):25-31. PubMed ID: 25042866 [TBL] [Abstract][Full Text] [Related]
29. New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials. Gorlia T; Stupp R; Brandes AA; Rampling RR; Fumoleau P; Dittrich C; Campone MM; Twelves CC; Raymond E; Hegi ME; Lacombe D; van den Bent MJ Eur J Cancer; 2012 May; 48(8):1176-84. PubMed ID: 22464345 [TBL] [Abstract][Full Text] [Related]
30. Glioblastoma: Targeting the autophagy in tumorigenesis. Yang K; Niu L; Bai Y; Le W Brain Res Bull; 2019 Nov; 153():334-340. PubMed ID: 31580908 [TBL] [Abstract][Full Text] [Related]
33. A reignited debate over the cell(s) of origin for glioblastoma and its clinical implications. Fan X; Xiong Y; Wang Y Front Med; 2019 Oct; 13(5):531-539. PubMed ID: 31313083 [TBL] [Abstract][Full Text] [Related]
34. Exploiting radiation immunostimulatory effects to improve glioblastoma outcome. Awada H; Paris F; Pecqueur C Neuro Oncol; 2023 Mar; 25(3):433-446. PubMed ID: 36239313 [TBL] [Abstract][Full Text] [Related]
35. Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone. Lemée JM; Clavreul A; Menei P Neuro Oncol; 2015 Oct; 17(10):1322-32. PubMed ID: 26203067 [TBL] [Abstract][Full Text] [Related]
36. Extra-CNS metastasis from glioblastoma: a rare clinical entity. Awan M; Liu S; Sahgal A; Das S; Chao ST; Chang EL; Knisely JP; Redmond K; Sohn JW; Machtay M; Sloan AE; Mansur DB; Rogers LR; Lo SS Expert Rev Anticancer Ther; 2015 May; 15(5):545-52. PubMed ID: 25907706 [TBL] [Abstract][Full Text] [Related]
37. Brain tumour stem cells: implications for cancer therapy and regenerative medicine. Sanchez-Martin M Curr Stem Cell Res Ther; 2008 Sep; 3(3):197-207. PubMed ID: 18782002 [TBL] [Abstract][Full Text] [Related]
38. Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma. Qazi MA; Salim SK; Brown KR; Mikolajewicz N; Savage N; Han H; Subapanditha MK; Bakhshinyan D; Nixon A; Vora P; Desmond K; Chokshi C; Singh M; Khoo A; Macklin A; Khan S; Tatari N; Winegarden N; Richards L; Pugh T; Bock N; Mansouri A; Venugopal C; Kislinger T; Goyal S; Moffat J; Singh SK Cell Rep; 2022 Sep; 40(13):111420. PubMed ID: 36170831 [TBL] [Abstract][Full Text] [Related]
39. Utility of the Cerebral Organoid Glioma 'GLICO' Model for Screening Applications. Weth FR; Peng L; Paterson E; Tan ST; Gray C Cells; 2022 Dec; 12(1):. PubMed ID: 36611949 [TBL] [Abstract][Full Text] [Related]
40. Scalp Metastasis from Glioblastoma Multiforme: A Case Report and Literature Review. Mammi M; Altieri R; Agnoletti A; Pacca P; Franchino F; Garbossa D; Ducati A; Melcarne A Surg Technol Int; 2017 Feb; 30():477-481. PubMed ID: 28182828 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]